Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Barbara Ann Karmanos Cancer Institute
ClinicalTrials.gov Identifier:
NCT00004024
First received: November 1, 1999
Last updated: April 3, 2013
Last verified: April 2013